Best Practice & Research Clinical Rheumatology
Volume 20, Issue 2 , Pages 353-368, April 2006

Adolescent development and SLE

  • Joyce E. Davidson, BSc, MBChB, MRCP, FRCPCH (Consultant in Paediatric Rheumatology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 141 201 0867.

Adolescence is a time of profound biological and psychosocial change. The management of a complex chronic condition such as systemic lupus erythematosus (SLE) during this period is a challenging but rewarding task for the clinician. Early diagnosis and optimal disease control is essential in order to facilitate normal adolescent development and minimize long-term disease sequelae. Current treatment regimens are associated with significant toxicity in young people, and there is a need for new, less toxic regimens. There are currently no controlled therapeutic studies in adolescents with SLE. Those involved in the care of these young people must ensure that they have appropriate access to specialist medical services while ensuring that their specific needs as adolescents in the health-care system are addressed.

Key words: systemic lupus erythematosus, adolescence, disease activity, outcome

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6942(05)00126-9

doi:10.1016/j.berh.2005.11.003

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 2 , Pages 353-368, April 2006